Nordic Nanovector is looking for an experienced lawyer to join our team.
Nordic Nanovector is looking for an experienced lawyer to join our team as Head of Legal and Compliance . The position is newly established, and the right candidate will get the opportunity to work in a fast-paced environment partnering with the Management Team on legal and compliance matters.
KEY REPONSIBILITIES
Legal
· Act as the contractual subject matter expert on developing and reviewing agreements and contracts with external partners and suppliers
· Responsible for all legal and governance processes
· Coordinate and optimise utilisation of legal workstreams
· Support senior management in strategic risk assessment
· Provide legal advice to other functions in the company
· Manage legal housekeeping
Compliance
· Working closely with the Vice President Investor Relations & Corporate Communications to further develop and implement compliance standards based on Oslo Stock Exchange laws and regulations.
· Manage the company's GDPR requirements, risk management and compliance training
Qualifications
· Cand.Jur, law
· About 10 years of experience in either a lawyer company or as an in-house lawyer in an international company
· Knowledge from working in/for a public company is a requirement
· Working within the pharmaceutical industry is a clear advantage
· Documented competence of corporate and securities laws and regulations
· Documented competence of tax and employment law
· Assertive and with excellent interpersonal and negotiating skills.
· High proficiency in English and Norwegian
LOCATION AND REPORTING LINE
The position and will be based in Oslo and reports to the Chief Financial Officer. The
flexibility to travel is required. Nordic Nanovector offers a challenging and exciting role in one of
Norway's most innovative pharmaceutical companies.
Level of compensation will reflect experience and qualifications.
We pride ourselves on our dedication to our mission to extend an improve the lives of patients with haematological cancers, and it is important to us that all members of our team are connected to this purpose.
Om bedriften
Nordic Nanovector's mission is to extend and improve the lives of patients with haematological cancers by developing and commercialising innovative antibody radionuclide conjugates (ARC).
Nordic Nanovector is committed to develop and deliver innovative therapies to patients to address major unmet medical needs and advance cancer care. The Company aspires to become a leader in the development of targeted therapies for haematological cancers. Nordic Nanovector's lead clinical-stage candidate is Betalutin®, a novel CD37-targeting antibody-radionuclide-conjugate designed to advance the treatment of non-Hodgkin's lymphoma (NHL). NHL is an indication with substantial unmet medical need, representing a growing market forecast to be worth nearly USD 29 billion by 2026. Nordic Nanovector intends to retain marketing rights and to actively participate in the commercialisation of Betalutin® in core markets.
Nordic Nanovector was established in Oslo in 2009 and is since March 2015 listed on the Oslo Stock Exchange.